Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2021

Feb 11, 2021

29821_dirs_2021-02-11_bb8e4224-03c9-479c-878d-1c63d72f20e6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2021-02-10

Reporting Person: Fitzgerald Joseph Michael (EVP & Pres, Interven Cardio)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-02-08 Common Stock G 3040.0000 $0.0000 Disposed 231603.0000 Direct
2021-02-10 Common Stock A 17995.0000 $0.0000 Acquired 249598.0000 Direct
2021-02-10 Common Stock F 8881.0000 $38.8500 Disposed 240717.0000 Direct
2021-02-08 Common Stock G 1520.0000 $0.0000 Acquired 6038.0000 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 68312.0000 Indirect

Footnotes

F1: This transaction involved a gift of securities by the reporting person to his children, two of whom share reporting person's household.

F2: Mr. Fitzgerald's holdings include 15 shares of common stock, which, due to an administrative error, had not been previously reported.

F3: On February 15, 2018, the reporting person was awarded a target number of performance share units under the Company's 2018 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2020 and subject to the completion of the concurrent three-year individual service period. On February 9, 2021, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied.

F4: The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose. Shares held by one of his children, who is no longer considered a dependent, have been removed from this report.

F5: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.